Adherence Inhibition of Cronobacter sakazakii to Intestinal Epithelial Cells by Lactoferrin
详细信息 查看全文
- 作者：Maria I. Quintero-Villegas ; Anja Wittke ; Robert Hutkins
- 刊名：Current Microbiology
- 出版年：2014
- 出版时间：October 2014
- 年：2014
- 卷：69
- 期：4
- 页码：574-579
- 全文大小：309 KB
- 参考文献：1. Actor JK, Hwang SA, Kruzel ML (2009) Lactoferrin as a natural immune modulator. Curr Pharm Des 15:1956-973 CrossRef
2. Appelmelk BJ, An YQ, Geerts M, Thijs BG, Boer HA et al (1994) Lactoferrin is a lipid A-binding protein. Infect Immun 62:2628-632
3. Araújo AN, Giugliano LG (2001) Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic / Escherichia coli to HeLa cells. BMC Microbiol 1:25 CrossRef
4. Arnold RR, Brewer M, Gauthier JJ (1980) Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 28:893-98
5. Bessler HC, Oliveira IR, Giugliano LG (2006) Human milk glycoproteins inhibit the adherence of / Salmonella typhimurium to HeLa cells. Microbiol Immunol 50:877-82 CrossRef
6. Beuchat LR, Kim H, Gurtler JB, Lin LC, Ryu JH et al (2009) / Cronobacter sakazakii in foods and factors affecting its survival, growth, and inactivation. Int J Food Microbiol 136:204-13 CrossRef
7. Bowen AB, Braden CR (2006) Invasive / Enterobacter sakazakii disease in infants. Emerg Infect Dis 12:1185-1893 CrossRef
8. Brandenburg K, Jürgens G, Müller M, Fukuoka S, Koch MH (2001) Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol Chem 382:1215-225
9. Brock JH (2002) The physiology of lactoferrin. Biochem Cell Biol 80:1- CrossRef
10. Bullen JJ, Rogers HJ, Leigh L (1972) Iron-binding proteins in milk and resistance to / Escherichia coli infection in infants. BMJ 1:69-5 CrossRef
11. Cozens D, Read RC (2012) Anti-adhesion methods as novel therapeutics for bacterial infections. Expert Rev Anti-infect Ther 10:1457-468 CrossRef
12. Dalmastri C, Valenti P, Visca P, Vittorioso P, Orsi N (1998) Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. Microbiologica 11:225-30
13. DeVinney R, Gauthier A, Abe A, Finlay BB (1999) Enteropathogenic / Escherichia coli: a pathogen that inserts its own receptor into host cells. Cell Mol Life Sci 55:961-76
14. Farnaud S (2003) Lactoferrin—a multifunctional protein with antimicrobial properties. Mol Immunol 40:395-05 CrossRef
15. Flores-Villase?or H, Canizalez-Roman A, Reyes-Lopez M, Nazmi K, de la Garza M et al (2010) Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant / Staphylococcus aureus and / Escherichia coli. Biometals 23:569-78 CrossRef
16. Gomez HF, Ochoa TJ, Carlin LG, Cleary TG (2003) Human lactoferrin impairs virulence of / Shigella flexneri. J Infect Dis 187:87-5 CrossRef
17. Gomez HF, Herrera-Insua I, Siddiqui MM, Diaz-Gonzalez VA, Caceres E et al (2001) Protective role of human lactoferrin against invasion of / Shigella flexneri M90T. Adv Exp Med Biol 501:457-67 CrossRef
18. Goosney DL, Knoechel DG, Finlay BB (1999) Enteropathogenic / E. coli, Salmonella, and / Shigella: masters of host cell cytoskeletal exploitation. Emerg Infect Dis 5:216-23 CrossRef
19. Healy B, Cooney S, O’Brien S, Iversen C, Whyte P et al (2010) / Cronobacter ( / Enterobacter sakazakii): an opportunistic foodborne pathogen. Foodborne Pathog Dis 7:339-50 CrossRef
20. Hunter CJ, Bean JF (2013) / Cronobacter: an emerging opportunistic pathogen associated with neonatal meningitis, sepsis and necrotizing enterocolitis. J Perinatol 33:581-85 CrossRef
21. Jenssen H, Hancock REW (2009) Antimicrobial properties of lactoferrin. Biochimie 91:19-9 CrossRef
22. Kalmar JR, Arnold RR (1998) Killing of / Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun 56:2552-557
23. Kawasaki Y, Tazume S, Shimizu K, Matsuzawa H, Dosako S et al (2000) Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic / Escherichia coli to host cells. Biosci Biotechnol Biochem 64:348-54 CrossRef
24. Kim KP, Loessner MJ (2008) / Enterobacter sakazakii invasion in human intestinal Caco-2 cells requires the host cell cytoskeleton and is enhanced by disruption of tight junction. Infect Immun 76:562-70 CrossRef
25. Kruzel ML, Harari Y, Mailman D, Actor JK (2002) Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin Exp Immunol 130:25-1 CrossRef
26. Lai KK (2001) / Enterobacter sakazakii infections among neonates, infants, children, and adults. Case reports and a review of the literature. Medicine 80:113-22 CrossRef
27. Legrand D, Pierce A, Elass E, Carpentier M, Mariller C et al (2008) Lactoferrin structure and functions. Adv Exp Med Biol 606:163-94 CrossRef
28. Liu Q, Mittal R, Emami CN, Iversen C, Ford HR et al (2012) Human isolates of / Cronobacter sakazakii bind efficiently to intestinal epithelial cells in vitro to induce monolayer permeability and apoptosis. J Surg Res 176:437-47 CrossRef
29. Liu Y, Cai X, Zhang X, Gao Q, Yang X et al (2006) Real time PCR TaqMan and SYBR Green for detection of / Enterobacter sakazakii in infant formula. J Micriobiol Methods 65:21-1 CrossRef
30. Lonnerdal B, Suzuki YA (2013) Lactoferrin. In: McSweeney PLH, Fox PX (eds) Advanced dairy chemistry: volume 1A: proteins: basic aspects 4th edn. Springer, New York, pp 295-16
31. Martínez I, Wallace G, Zhang C, Legge R, Benson AK et al (2009) Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl Environ Microbiol 75:4175-184 CrossRef
32. Ochoa TJ, Brown EL, Guion CE, Chen JZ, McMahon RJ et al (2006) Effect of lactoferrin on enteroaggregative E. coli (EAEC) 1. Biochem Cell Biol 84:369-76 CrossRef
33. Ochoa TJ, Noguera-Obenza M, Cleary TG (2004) Lactoferrin blocks the initial host cell attachment mechanism of enteropathogenic / E. coli (EPEC). Adv Exp Med Biol 554:463-66 CrossRef
34. Ochoa TJ, Noguera-Obenza M, Ebel F, Guzman CA, Gomez HF et al (2003) Lactoferrin impairs type III secretory system function in enteropathogenic / Escherichia coli. Infect Immun 71:5149-155 CrossRef
35. Ochoa TJ, Cleary TG (2009) Effect of lactoferrin on enteric pathogens. Biochimie 91:30-4 CrossRef
36. Ofek I, Hasty DL, Doyle RJ (2003) Bacterial adhesion to animal cells and tissues. ASM Press, Washington, D.C
37. Orsi N (2004) The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 17:189-96 CrossRef
38. Qiu J (1998) Human milk lactoferrin inactivates two putative colonization factors expressed by / Haemophilus influenzae. Proc Natl Acad Sci 95:12641-2646 CrossRef
39. Quintero M, Maldonado M, Perez-Munoz M, Jimenez R, Fangman T et al (2011) Adherence Inhibition of / Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides. Curr Microbiol 62:1448-454 CrossRef
40. Rai D, Adekman AS, Zhuang W, Rai GP, Boettcher J et al (2011) Longitudinal changes in lactoferrin concentrations in human milk—a global systematic review. Crit Rev Food Sci Nutr. doi:10.1080/10408398.2011.642422
41. Ronayne de Ferrer PA, Baroni A, Sambucetti ME, Lopez NE, Ceriani-Cernadas JM (2000) Lactoferrin levels in term and preterm milk. J Am Coll Nutr 19:370-73 CrossRef
42. Searle LEJ, Best A, Nunez A, Salguero FJ, Johnson L (2009) A mixture containing galactooligosaccharide, produced by the enzymic activity of / Bifidobacterium bifidum, reduces / Salmonella enterica serovar Typhimurium infection in mice. J Med Microbiol 58:37-8 CrossRef
43. Shahriar F, Gordon JR, Simko E (2006) Identification of lipopolysaccharide-binding proteins in porcine milk. Can J Vet Res 70:243-50
44. Shaker R, Osaili T, Al-Omary W, Jaradat Z, Al-Zuby M (2007) Isolation of / Enterobacter sakazakii and other / Enterobacter sp. from food and food production environments. Food Control 18:1241-245 CrossRef
45. Sharon N (2006) Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta 1760:527-37 CrossRef
46. Sharon N, Ofek I (2002) Fighting infectious diseases with inhibitors of microbial adhesion to host tissues. Crit Rev Food Sci Nutr 42:267-72 CrossRef
47. Sharon N, Ofek I (2000) Safe as mother’s milk: carbohydrates as future anti-adhesion drugs for bacterial diseases. Glycoconj J 17:659-64 CrossRef
48. Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW (2006) Prebiotic galactooligosaccharides reduce adherence of enteropathogenic / Escherichia coli to tissue culture cells. Infect Immun 74:6920-928 CrossRef
49. Shoaf-Sweeney KD, Hutkins RW (2008) Adherence, anti-adherence, and oligosaccharides: preventing pathogens from sticking to the host. Adv Food Nutr Res 55:101-61 CrossRef
50. Valenti P, Antonini G (2005) Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 62:2576-587 CrossRef
51. Wakabayashi H, Yamauchi K, Takase M (2008) Inhibitory effects of bovine lactoferrin and lactoferricin B on / Enterobacter sakazakii. Biocontrol Sci 13:29-2 CrossRef
52. Ward PP, Uribe-Luna S (2002) Lactoferrin and host defense. Biochem Cell Biol 80:95-02 CrossRef
53. Yamauchi K, Tomita M, Giehl TJ, Ellison RT (1993) Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 61:719-28
54. Yan QQ, Condell O, Power K, Butler F, Tall BD et al (2012) / Cronobacter species (formerly known as / Enterobacter sakazakii) in powdered infant formula: a review of our current understanding of the biology of this bacterium. J Appl Microbiol 113:1-5 CrossRef
55. Yekta MA, Verdonck F, Broeck WVD, Goddeerins BM, Cox E et al (2010) Lactoferrin inhibits / E. coli O157: H7 growth and attachment to intestinal epithelial cells. Vet Med 55:359-68 - 作者单位：Maria I. Quintero-Villegas (1)
Anja Wittke (2)
Robert Hutkins (1)
1. University of Nebraska Lincoln, Food Science and Technology, Lincoln, NE, USA
2. Mead Johsnon Nutrition, Evansville, IN, USA - ISSN：1432-0991
文摘
Cronobacter sakazakii is now recognized as an opportunistic pathogen and has been implicated in rare but severe cases of necrotizing enterocolitis, meningitis, and sepsis in neonates. The first step in bacterial pathogenesis requires that the organism adheres to host cells surfaces; therefore, agents that inhibit adherence might be useful for preventing infections. Lactoferrin, an iron binding protein found in milk, has been shown to inhibit bacterial adherence by direct interaction and disruption of bacterial surfaces. Therefore, the goal of this research was to assess the ability of two different types of bovine lactoferrin, alone and in combination with a 1:1 blend of galactooligosaccharides and polydextrose, to inhibit adherence of C. sakazakii to a HEp-2 human cell line. Results showed that the adherence of C. sakazakii was significantly reduced at a minimum lactoferrin concentration of 10?mg/ml. However, in combination with the oligosaccharide blend, no synergistic effect was observed in adherence inhibition. These results suggest that lactoferrin might interact with C. sakazakii and directly inhibit adhesion to tissue culture cells.